Baxter International (BAX) has issued an announcement.
Baxter International Inc. is exploring strategic options for its Kidney Care business, considering a potential sale to private equity investors as an alternative to the previously planned spinoff. The company is committed to executing this separation in the second half of 2024 to maximize stockholder value. While discussions are ongoing and no definitive structure has been decided, Baxter is progressing with the spinoff plans and remains transparent about the exploration process, despite the inherent uncertainty and the possibility of unforeseen costs or disruptions.
Learn more about BAX stock on TipRanks’ Stock Analysis page.
